Idogen announces outcome of exercise period for warrants of series TO 5
The board of directors of Idogen AB ("Idogen" or "the Company") today announces the outcome of the exercise of warrants of series TO 5 (“Warrants”), which were issued in connection with the Company's rights issue of units which was announced the 17 of December 2021 (“the Rights issue”). The subscription rate was 1.1 percent and Idogen receives approximately SEK 280 thousand before issue costs. Idogen issued a total of 16,478,910 units in the the Rights issue, each unit containing three (3) shares and six (6) Warrants. Three (3) Warrants entitled the holder to subscribe for one (1)